62.36
62.36 (0%)
As of Feb 14, 2025
Haemonetics Corp [HAE]
Source:
Company Overview
Haemonetics is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. When used in this report, the terms we, us, our and the Company mean Haemonetics.
| Country | United States |
| Headquarters | boston, massachusetts |
| Phone Number | (781)848-7100 |
| Industry | manufacturing |
| CEO | Christopher A. Simon |
| Website | www.haemonetics.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $348.5 |
| Operating Profit | $59 |
| Net Income | $37.5 |
| Net Cash | $142 |
Profit Ratios
| Gross Margin | $193.5 |
| Operating Margin | 16.9 |
| Profit as % of Revenues | 516.2% |
| Profit as % of Assets | 1.6% |
| Profit as % of Stockholder Equity | 4.1% |
Management Effectiveness
| Return on Equity | 4.1% |
| Return on Assets | 1.5% |
| Turnover Ratio | 14.8% |
| EBITA | $71.3 |
Balance Sheet and Cash Flow Measures
| Total Assets | $2,531.3 |
| Total Liabilities | $1,624.4 |
| Operating Cash Flow | $65.2 |
| Investing Cash Flow | $-179.9 |
| Financing Cash Flow | $260.3 |
